Docetaxel Plus Ramucirumab With Primary Prophylactic Pegylated Granulocyte-Colony Stimulating Factor Support for Elderly Patients With Advanced NSCLC: A Multicenter Prospective Single Arm Phase 2 Trial: DRAGON Study (WJOG9416L)-Reference-Cited by-同舟云学术

Docetaxel Plus Ramucirumab With Primary Prophylactic Pegylated Granulocyte-Colony Stimulating Factor Support for Elderly Patients With Advanced NSCLC: A Multicenter Prospective Single Arm Phase 2 Trial: DRAGON Study (WJOG9416L)

Published:2023-10 Issue:10 Volume:4 Page:100569
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Tachihara Motoko,Hata Akito,Tokito Takaaki,Hara Satoshi,Okada Hideaki,Miura Satoru,Sato Yuki,Tabata Eriko,Watanabe Hiroshi,Takayama Yusuke,Toyozawa Ryo,Ota Keiichi,Wakuda Kazushige,Nakamura Atsushi,Shimokawa Mototsugu,Yamamoto Nobuyuki,Nakagawa Kazuhiko

Funder

Eli Lilly Japan KK

Eli Lilly and Company

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference18 articles.

1. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The elderly lung cancer vinorelbine Italian study group;J Natl Cancer Inst,1999

2. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial;Gridelli;J Natl Cancer Inst,2003

3. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904);Kudoh;J Clin Oncol,2006

4. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial;Quoix;Lancet,2011

5. Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer;Socinski;Ann Oncol,2013